Skip to main content
. 2021 Dec 18;9:194. doi: 10.1186/s40478-021-01277-5

Table 2.

Detailed clinical characteristics of patients with de novo p.Thr8Met SETX variants. NR: not reported

Current study Current study Individual described by Kitao et al., 2020
Patient Patient 1 Patient 2 Proband
Age at last review 10 years 14 years 29 years
Gender Male Male Male
Country of parental origin Mother: Irish Father: Irish-Canadian Mixed Northern European-Italian Japan
Birth weight/gestational age 3.2 kg / 41 weeks 3.3 kg / 40 weeks NR
Current height (centile)  < 1%ile 133 cm (< 1%ile) 130 cm (< 1%ile)
Current weight (centile) 19.5 kg (< 1%ile) 30 kg (< 1%ile) 21 kg (< 1%ile)
Feeding/swallowing difficulties Failure to thrive from an early age Failure to thrive and diarrhea (age 4) NR
Respiratory function Recurrent episodes of croup, recurrent pneumonias, moderate obstructive sleep apnea Nocturnal CPAP, restrictive lung disease Respiratory failure at age 20 requiring tracheostomy with positive-pressure ventilation (TPPV)
G-tube and age at dependency No Age 12 NR
Developmental/academic history Grade 5, above average Grade 9, grade A average NR
Communication Excellent vocabulary and spelling, severe dysarthria Excellent written communication, severe dysarthria No dysarthria
Gross motor Sat 7–8 months, crawled 18 months, cruised 2 years, ambulated with walker until 9 years Delays in rolling, sitting, crawling, standing, walked at 14 months, ambulated until 12 years Walked at 2.5 years, ambulated until 12 years
Fine motor No pincer grasp, severely limited by hand contractures Severely limited by hand contractures Difficult to assess due to muscle weakness and contractures
Functional status Non-ambulatory (wheel-chair dependent), can use fork with assistance, fully dependent for most ADLs Non-ambulatory (wheel-chair dependent), fully dependent for ADLs, required 24-h care Non-ambulatory at 12 years
Facial weakness Dysarthria, lower facial weakness Myopathic facies, mild bilateral ptosis, dysarthric speech Weakness of facial muscles
Tongue fasciculations Yes Yes (with associated atrophy) No
Axial hypotonia Significant (unable to sit unsupported for 20 s) Significant (unstable when leaning forward in his chair) Decreased tone
Appendicular hypertonia/spasticity Moderate in legs bilaterally Mild NR
Muscle weakness Generalized weakness, distal more than proximal Generalized weakness, distal more than proximal Distal muscle weakness
Muscle atrophy Generalized atrophy, most notable of thenar and hypothenar eminences Generalized atrophy, most notable in fingers Generalized muscle atrophy
Sensory exam Intact vibration, proprioception mildly decreased Pain and temperature preserved, vibration and proprioception mildly decreased Impairment in all modalities distally
Deep tendon reflexes Absent throughout 1 + throughout Absent throughout
Extensor plantar response Bilaterally extensor Bilaterally extensor Absent
Scoliosis Severe scoliosis with a Cobb angle of 75 degrees Marked left-sided thoracic scoliosis Severe scoliosis, Cobb angle of 71 degrees
Contractures Bilateral club feet at birth, severe hand contractures Severe finger, knee, ankle contractures Hand contractures
Cardiac function Echocardiogram (age 9): normal Normal NR
Other CSF, CPK, serum neuromuscular antibody panel, PMP22, MPZ, ERG2, LITAF, PRX, NFL sequencing, chromosomal microarray, and mitochondrial DNA sequencing: negative Karyotype, Fragile X, FISH and methylation studies for Prader-Willi and Angelman syndromes, CPK, sequencing of PRX, PMP22, EGR2, MPZ and GJB1: negative Comprehensive gene analysis of hereditary peripheral neurological diseases by next-generation sequencing: negative
Brain MRI Several non-specific tiny white matter hyperintensities in the centrum semiovale and peritrigonal regions bilaterally Non-specific left peritrigonal increased T2 and FLAIR signal Normal
Spine MRI Normal Normal NR
EMG/NCS Severe axonal loss and slowed conduction velocity (Table 1) Severe axonal loss and slowed conduction velocity (Table 1) Decreased compound muscle action potential amplitudes and reduced motor nerve conduction velocity with absent sensory nerve action potentials
SETX (NM_015046.5) c.23C > T (de novo) c.23C > T (de novo) c.23C > T (de novo)
Genomic position (Hg19) chr9:135224793G > A chr9:135224793G > A chr9:135224793G > A
Predicted effect on protein p.Thr8Met p.Thr8Met p.Thr8Met
Type of mutation Missense Missense Missense